
Boehringer partners PureTech to develop immuno-oncology candidates
Boehringer Ingelheim has formed an alliance with US-based PureTech Health to develop new drug candidates for a variety of targets using lymphatic targeting technology. The research collaboration will initially work on Boehringer’s immuno-oncology candidate for […]